Fierce Biotech News & Reports
Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
A look at the R&D landscape in obesity, led by GLP-1s - Fierce …
Mar 19, 2024 · If you’re feeling like overnight obesity became the indication du jour, you’re not alone. Novo Nordisk was granted approval for semaglutide to be marketed as Wegovy for chronic weight ...
Gilead gives up on $15M MASH bet after mulling preclinical data
Oct 11, 2024 · The U.S. drugmaker “mutually agreed” to terminate its collaboration with South Korean biotech Yuhan for a pair of MASH therapies.
Supernus links depression drug to fast responses in ph. 2 trial
Oct 18, 2024 · Supernus Pharmaceuticals has linked its mTORC1 activator to rapid improvements in adults with major depressive disorder (MDD) in a small trial, pointing to one possible path forward for a ...
Fierce Biotech Fundraising Tracker 2024
6 days ago · A new year means a new Fierce Biotech Fundraising Tracker to record all the venture capital being funneled into the industry for 2024. We're bumping up our reporting criteria from last year's ...
Fierce Biotech Layoff Tracker 2024
4 days ago · March—18 companies. March 29 - Mustang Bio: Cell therapy-focused Mustang has laid off an undisclosed number of workers. The company declined to disclose how many employees would be impacted ...
Sanofi lifts lid on data behind tolebrutinib’s mixed MS studies
Sep 20, 2024 · Sanofi’s safety and tolerability analysis showed 4.1% of people on tolebrutinib had liver enzyme levels of at least three times the upper limit of normal, compared to 1.6% of the patients taking ...
Regeneron to fill gaps in obesity, break ground in cell therapy
Feb 2, 2024 · Regeneron wants to improve on obesity care with a muscle-preservation approach, while elsewhere, the biopharma charts a new course in cell therapy.
Gritstone files for bankruptcy in hope of keeping R&D afloat
Oct 10, 2024 · Gritstone bio may have left no stone unturned when it came to searching for a financial rescue, but the vaccine biotech has decided that all roads now lead to bankruptcy.. The cash-strapped ...
After massive $401M raise, ElevateBio lets 13% of staff go - Fierce …
Oct 26, 2023 · Even with $401 million in the bank—thanks to one of the year’s largest biotech fundraisings—ElevateBio is still shaving off some preclinical work resulting in layoffs that will affect 13% of ...